Cargando…

Drug Burden Index in older adults: theoretical and practical issues

Anticholinergic and sedative medications are commonly used in older adults and are associated with adverse clinical outcomes. The Drug Burden Index was developed to measure the cumulative exposure to these medications in older adults and its impact on physical and cognitive function. This narrative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouladjian, Lisa, Gnjidic, Danijela, Chen, Timothy F, Mangoni, Arduino A, Hilmer, Sarah N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166346/ https://www.ncbi.nlm.nih.gov/pubmed/25246778 http://dx.doi.org/10.2147/CIA.S66660

Ejemplares similares

Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications
por: Kouladjian O’Donnell, Lisa, et al.
Publicado: (2019)

The anticholinergic burden: from research to practice
por: Hilmer, Sarah N, et al.
Publicado: (2022)

Impact of a Comprehensive Intervention Bundle Including the Drug Burden Index on Deprescribing Anticholinergic and Sedative Drugs in Older Acute Inpatients: A Non-randomised Controlled Before-and-After Pilot Study
por: Fujita, Kenji, et al.
Publicado: (2023)

Correction to: Implementation of the goal-directed medication review electronic decision support system (G-MEDSS)© into home medicines review: a protocol for a clusterrandomised clinical trial in older adults
por: O’Donnell, Lisa Kouladjian, et al.
Publicado: (2020)

Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)© into home medicines review: a protocol for a cluster-randomised clinical trial in older adults
por: Kouladjian O’Donnell, Lisa, et al.
Publicado: (2020)

Health professionals’ and researchers’ opinions on conducting clinical deprescribing trials
por: Clough, Alexander J., et al.
Publicado: (2019)

The Feasibility of Using N-Of-1 Trials to Investigate Deprescribing in Older Adults with Dementia: A Pilot Study
por: Clough, Alexander J., et al.
Publicado: (2019)

The Prevalence of Adverse Drug Reactions and Adverse Drug Events from Heart Failure Medications in Frail Older Adults: A Systematic Review
por: Duong, Mai H., et al.
Publicado: (2022)

Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the Medication-Related Burden Quality of Life (MRB-QoL) tool
por: Mohammed, Mohammed A, et al.
Publicado: (2018)

BURDEN OF POTENTIALLY INAPPROPRIATE MEDICATIONS AMONG OLDER VETERANS WITH PAIN AND DEMENTIA
por: Allore, Heather, et al.
Publicado: (2019)

Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer’s Disease: A National Population Cohort Study
por: Gnjidic, Danijela, et al.
Publicado: (2014)

Pharmacist-led intervention to improve medication use in older inpatients using the Drug Burden Index: a study protocol for a before/after intervention with a retrospective control group and multiple case analysis
por: Dearing, Marci Elizabeth, et al.
Publicado: (2020)

Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions
por: Wu, Harry, et al.
Publicado: (2021)

Caregivers’ Perspectives of Medication Management Advice for People With Dementia at Hospital Discharge
por: Sawan, Mouna, et al.
Publicado: (2020)

Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study
por: Jokanovic, Natali, et al.
Publicado: (2019)

Comparing Effects of Polypharmacy on Inflammatory Profiles in Older Adults and Mice: Implications for Translational Aging Research
por: Wu, Harry, et al.
Publicado: (2022)

High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level
por: Gnjidic, Danijela, et al.
Publicado: (2013)

Validation and Adaptation of the Multidimensional Prognostic Index in an Older Australian Cohort
por: Bryant, Kimberley, et al.
Publicado: (2019)

Psychotropic medications in older people in residential care facilities and associations with quality of life: a cross-sectional study
por: Harrison, Stephanie L., et al.
Publicado: (2018)

Preferences for deprescribing antihypertensive medications amongst clinicians, carers and people living with dementia: a discrete choice experiment
por: Raghunandan, Rakhee, et al.
Publicado: (2023)

Development of a tool to evaluate medication management guidance provided to carers of people living with dementia at hospital discharge: a mixed methods study
por: Sawan, Mouna J, et al.
Publicado: (2022)

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
por: Erre, Gian Luca, et al.
Publicado: (2021)

Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing
por: Gemikonakli, Gizem, et al.
Publicado: (2022)

Systemic inflammation index, disease severity, and mortality in patients with COVID-19: a systematic review and meta-analysis
por: Mangoni, Arduino A., et al.
Publicado: (2023)

Patterns of high-risk prescribing and other factors in relation to receipt of a home medicines review: a prospective cohort investigation among adults aged 45 years and over in Australia
por: Du, Wei, et al.
Publicado: (2019)

Drug Burden Index in Older Adults with Psychiatric Illnesses: A Cross-Sectional Study
por: Chahine, Bahia
Publicado: (2023)

Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions
por: Anderson, Sarah L, et al.
Publicado: (2021)

Diurnal effects of polypharmacy with high drug burden index on physical activities over 23 h differ with age and sex
por: Tran, Trang, et al.
Publicado: (2022)

Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages
por: Mangoni, Arduino A., et al.
Publicado: (2021)

Aggregate Index of Systemic Inflammation (AISI), Disease Severity, and Mortality in COVID-19: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023)

Statin use and clinical outcomes in older men: a prospective population-based study
por: Gnjidic, Danijela, et al.
Publicado: (2013)

Use of Multiprognostic Index Domain Scores, Clinical Data, and Machine Learning to Improve 12-Month Mortality Risk Prediction in Older Hospitalized Patients: Prospective Cohort Study
por: Woodman, Richard John, et al.
Publicado: (2021)

Using the Drug Burden Index to identify older adults at highest risk for medication-related falls
por: Blalock, Susan J., et al.
Publicado: (2020)

Clinical implications of changes in hepatic drug metabolism in older people
por: Hilmer, Sarah N, et al.
Publicado: (2005)

Clinical and Biochemical Correlates of Serum L-Ergothioneine Concentrations in Community-Dwelling Middle-Aged and Older Adults
por: Sotgia, Salvatore, et al.
Publicado: (2014)

Non-steroidal anti-inflammatory drug (NSAID) related inhibition of aldosterone glucuronidation and arterial dysfunction in patients with rheumatoid arthritis: a cross-sectional clinical study
por: Crilly, Michael A, et al.
Publicado: (2011)

A Systematic Review of the Prognostic Significance of the Body Mass Index in Idiopathic Pulmonary Fibrosis
por: Zinellu, Angelo, et al.
Publicado: (2023)

The impact of in hospital patient-education intervention on older people’s attitudes and intention to have their benzodiazepines deprescribed: a feasibility study
por: Gnjidic, Danijela, et al.
Publicado: (2019)

Patterns of Drug Use and Serum Sodium Concentrations in Older Hospitalized Patients: A Latent Class Analysis Approach
por: Woodman, Richard J., et al.
Publicado: (2016)

Geriatric Medicine in an Aging Society: Up for a Challenge?
por: Mangoni, Arduino A.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0iu4o9v96hefc2lh8sqs6i5kf7